Association Between High Levels of Hepatitis B Core Antibody and Seroclearance of Hepatitis B e Antigen in Individuals With Chronic Hepatitis B Virus Infection.


Journal

Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association
ISSN: 1542-7714
Titre abrégé: Clin Gastroenterol Hepatol
Pays: United States
ID NLM: 101160775

Informations de publication

Date de publication:
06 2019
Historique:
received: 31 07 2018
revised: 12 09 2018
accepted: 17 09 2018
pubmed: 30 9 2018
medline: 21 10 2020
entrez: 30 9 2018
Statut: ppublish

Résumé

For chronic hepatitis B patients, hepatitis B e antigen (HBeAg) seroclearance signals a transition from an immunologically active phase to an inactive carrier state with a reduction in hepatitis B virus (HBV) DNA levels and a reduced risk of hepatocellular carcinoma (HCC).

Identifiants

pubmed: 30267868
pii: S1542-3565(18)31028-0
doi: 10.1016/j.cgh.2018.09.037
pii:
doi:

Substances chimiques

DNA, Viral 0
Hepatitis B Antibodies 0
Hepatitis B Surface Antigens 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

1413-1415

Informations de copyright

Copyright © 2019 AGA Institute. Published by Elsevier Inc. All rights reserved.

Auteurs

Jessica Liu (J)

Genomics Research Center, Academia Sinica, Taipei, Taiwan.

Hui-Han Hu (HH)

Genomics Research Center, Academia Sinica, Taipei, Taiwan.

Chia-Ling Chang (CL)

Genomics Research Center, Academia Sinica, Taipei, Taiwan.

Chin-Lan Jen (CL)

Genomics Research Center, Academia Sinica, Taipei, Taiwan.

Mei-Hsuan Lee (MH)

Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan.

Sheng-Nan Lu (SN)

Department of Gastroenterology, Chang-Gung Memorial Hospital, Kaohsiung, Taiwan.

Li-Yu Wang (LY)

MacKay College of Medicine, New Taipei City, Taiwan.

Quan Yuan (Q)

School of Public Health, Xiamen University, Xiamen, Fujian, China.

Ning-Shao Xia (NS)

School of Public Health, Xiamen University, Xiamen, Fujian, China.

Masaya Sugiyama (M)

The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.

Nao Nishida (N)

The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan.

Masashi Mizokami (M)

The Research Center for Hepatitis and Immunology, National Center for Global Health and Medicine, Ichikawa, Japan; Department of Hepatitis and Immunology, Nagoya City University Graduate School of Medical Science, Nagoya, Japan.

Chien-Jen Chen (CJ)

Academia Sinica, Taipei, Taiwan.

Pei-Jer Chen (PJ)

Division of Gastroenterology, Department of Internal Medicine, National Taiwan University Hospital, Taipei, Taiwan; Graduate Institute of Clinical Medicine, National Taiwan University, Taipei, Taiwan.

Hwai-I Yang (HI)

Genomics Research Center, Academia Sinica, Taipei, Taiwan; Institute of Clinical Medicine, National Yang-Ming University, Taipei, Taiwan. Electronic address: hiyang@gate.sinica.edu.tw.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH